These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34258818)

  • 1. A molecular hybrid comprising AS1411 and PDGF-BB aptamer, cholesterol, and doxorubicin for inhibiting proliferation of SW480 cells.
    Rotkrua P; Lohlamoh W; Watcharapo P; Soontornworajit B
    J Mol Recognit; 2021 Nov; 34(11):e2926. PubMed ID: 34258818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
    Lohlamoh W; Soontornworajit B; Rotkrua P
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Colorectal Cancer Cell Proliferation by Regulating Platelet-Derived Growth Factor B Signaling with a DNA Aptamer.
    Sae-Lim S; Soontornworajit B; Rotkrua P
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):487-494. PubMed ID: 30803211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.
    Subramanian N; Raghunathan V; Kanwar JR; Kanwar RK; Elchuri SV; Khetan V; Krishnakumar S
    Mol Vis; 2012; 18():2783-95. PubMed ID: 23213278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model.
    Zavvar T; Babaei M; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M
    Int J Pharm; 2020 Mar; 578():119091. PubMed ID: 32007591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
    Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
    Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
    Fang K; Wang L; Huang H; Dong S; Guo Y
    Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.
    Liang X; Wang Y; Shi H; Dong M; Han H; Li Q
    Int J Nanomedicine; 2021; 16():2569-2584. PubMed ID: 33833512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery.
    Nie L; Sun S; Sun M; Zhou Q; Zhang Z; Zheng L; Wang L
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of doxorubicin using a colorectal cancer-specific ssDNA aptamer.
    Li W; Chen H; Yu M; Fang J
    Anat Rec (Hoboken); 2014 Dec; 297(12):2280-8. PubMed ID: 25044297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
    Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin.
    Yao F; An Y; Li X; Li Z; Duan J; Yang XD
    Int J Nanomedicine; 2020; 15():2119-2129. PubMed ID: 32280210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.
    Zhang W; Zhou R; Yang Y; Peng S; Xiao D; Kong T; Cai X; Zhu B
    Cell Prolif; 2021 Sep; 54(9):e13105. PubMed ID: 34382270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
    Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
    Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Bivalent Aptamer-DNA Carrier-Doxorubicin Conjugates for Targeted Killing of Esophageal Squamous Cell Carcinoma Cells.
    Zhang T; Yin K; Niu X; Bai X; Wang Z; Ji M; Yuan B
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.